32.84
前日終値:
$32.05
開ける:
$32.35
24時間の取引高:
1.48M
Relative Volume:
1.12
時価総額:
$2.83B
収益:
$191.42M
当期純損益:
$-111.83M
株価収益率:
-24.78
EPS:
-1.3253
ネットキャッシュフロー:
$-76.77M
1週間 パフォーマンス:
+11.59%
1か月 パフォーマンス:
+15.98%
6か月 パフォーマンス:
+24.91%
1年 パフォーマンス:
+0.00%
Heartflow Inc Stock (HTFL) Company Profile
名前
Heartflow Inc
セクター
電話
650-241-1221
住所
135 MAIN STREET, SUITE 1000, SAN FRANCISCO
Compare HTFL vs VEEV, BTSG, TEM, HQY, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
HTFL
Heartflow Inc
|
32.84 | 2.83B | 191.42M | -111.83M | -76.77M | -1.3253 |
|
VEEV
Veeva Systems Inc
|
154.85 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
64.43 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
48.79 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
86.33 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
67.04 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-28 | 開始されました | Wells Fargo | Overweight |
| 2025-09-02 | 開始されました | Canaccord Genuity | Buy |
| 2025-09-02 | 開始されました | JP Morgan | Overweight |
| 2025-09-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2025-09-02 | 開始されました | Piper Sandler | Overweight |
| 2025-09-02 | 開始されました | Stifel | Buy |
すべてを表示
Heartflow Inc (HTFL) 最新ニュース
Lobbying Update: $90,000 of HEARTFLOW INC. lobbying was just disclosed - Quiver Quantitative
Piper Sandler Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $38 - Moomoo
HeartFlow Inc (HTFL) CEO John Farquhar Sells 22,562 Shares - GuruFocus
Heartflow CEO John Farquhar sells $643,017 in company stock - Investing.com UK
Heartflow CEO John Farquhar sells $643,017 in company stock By Investing.com - Investing.com India
Heartflow (HTFL) CEO Farquhar sells 22,562 shares under Rule 10b5-1 plan - Stock Titan
HeartFlow Stock Jumps as Wall Street Stays Bullish - TipRanks
Piper Sandler reiterates Heartflow stock rating on plaque revenue - Investing.com UK
Why HeartFlow, Inc. Shares Are Surging Today - TipRanks
[144] Heartflow, Inc. SEC Filing - Stock Titan
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? - AOL.com
Patent Infringement Lawsuit Alleges "Piracy" of AI-Driven Medical Technology - The National Law Review
A Look At HeartFlow (HTFL) Valuation As Analyst Fair Value Diverges From Current Share Price - Yahoo Finance
Stifel reiterates Heartflow stock rating on clinical data strength - Investing.com
Carlyle Group Inc.'s HeartFlow Inc(HTFL) Holding History - GuruFocus
TFC Financial Management, Inc.'s HeartFlow Inc(HTFL) Holding History - GuruFocus
HTFL Q1 2026 Earnings: EPS Misses Estimates, Stock Rises 8.4% on Broader OptimismEarnings Outlook Update - newsline.com
Heartflow Inc. (HTFL) Surges 3.1% as Bulls Test Key Resistance at $30.74PCR Mean Reversion - newsline.com
Heartflow Inc. (HTFL) Q1 2026 Earnings: EPS Misses Estimates Amid Key Operational DevelopmentsBook Value Growth - newsline.com
HeartFlow Q1 earnings call highlights - MSN
12 West Capital Management LP's HeartFlow Inc(HTFL) Holding History - GuruFocus
A Quick Look at Today's Ratings for Heartflow(HTFL.US), With a Forecast Between $35 to $37 - Moomoo
Heartflow CMO Campbell Rogers sells $261,266 of common stock By Investing.com - Investing.com South Africa
Heartflow CMO Campbell Rogers sells $261,266 of common stock - Investing.com
Heartflow (HTFL) CMO sells 9,219 shares after option exercise under 10b5-1 plan - Stock Titan
Earnings call transcript: HeartFlow Q1 2026 beats EPS expectations, stock falls - Investing.com
Why HeartFlow’s Stock Is Suddenly Sinking Hard - TipRanks
HTFL (NASDAQ: HTFL) Form 144 lists 86,240,828-share resale; recent trades noted - Stock Titan
Heartflow (HTFL) Stock Today: Drops -9.43%, Key Support at $24.36 2026-05-18Diamond Pattern - newsline.com
Why HeartFlow Stock Is Racing Higher Today - TipRanks
Companies Like HeartFlow (NASDAQ:HTFL) Are In A Position To Invest In Growth - Sahm
HTFL Maintained by Canaccord Genuity -- Price Target Lowered to $37 - GuruFocus
Bain Capital Life Sciences holds 12.18% in Heartflow (HTFL) - Stock Titan
Heartflow revenue up 41% to USD 52.6M in Q1 2026 - Medical Buyer
HeartFlow PT Raised to $35 as Strong Execution Meets Premium Valuation, Supporting Hold Rating - TipRanks
Canaccord lowers Heartflow stock price target on valuation despite strong results - Investing.com Nigeria
Canaccord lowers Heartflow stock price target on valuation despite strong results By Investing.com - Investing.com South Africa
Heartflow's Q1 2026 Beat: Is This the Turning Point for HTFL - Kavout
Heartflow, Inc. Stock 12‑Month Price Target Cut to $37, Implies 15% Upside - TradingView
HTFL SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus
HeartFlow (HTFL) Reports Strong Q1 2026 Earnings with 41% Revenue Growth - GuruFocus
HTFL Adjusts FY26 Gross Margin Outlook Amid Strong Earnings Cons - GuruFocus
Heartflow Q1 Earnings Call Highlights - sharewise.com
Heartflow (HTFL) Reports Strong Q1 Revenue Growth - GuruFocus
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript Summary - Moomoo
Why HeartFlow Stock Is Falling Despite AI Momentum - TipRanks
Earnings call transcript: HeartFlow Q1 2026 beats EPS forecast - Investing.com
Earnings call transcript: HeartFlow Q1 2026 beats EPS forecast By Investing.com - Investing.com Nigeria
Transcript: HeartFlow Q1 2026 Earnings Conference Call - Benzinga
Heartflow Inc (HTFL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):